annual EBIT:
-$442.90M+$129.06M(+22.56%)Summary
- As of today (May 29, 2025), BBIO annual earnings before interest & taxes is -$442.90 million, with the most recent change of +$129.06 million (+22.56%) on December 31, 2024.
- During the last 3 years, BBIO annual EBIT has risen by +$96.77 million (+17.93%).
- BBIO annual EBIT is now -910.76% below its all-time high of -$43.82 million, reached on December 31, 2017.
Performance
BBIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$127.47M+$108.95M(+46.08%)Summary
- As of today (May 29, 2025), BBIO quarterly earnings before interest & taxes is -$127.47 million, with the most recent change of +$108.95 million (+46.08%) on March 31, 2025.
- Over the past year, BBIO quarterly EBIT has dropped by -$114.78 million (-904.55%).
- BBIO quarterly EBIT is now -819.34% below its all-time high of $17.72 million, reached on June 30, 2022.
Performance
BBIO quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$557.68M-$114.78M(-25.91%)Summary
- As of today (May 29, 2025), BBIO TTM earnings before interest & taxes is -$557.68 million, with the most recent change of -$114.78 million (-25.91%) on March 31, 2025.
- Over the past year, BBIO TTM EBIT has dropped by -$95.64 million (-20.70%).
- BBIO TTM EBIT is now -1214.57% below its all-time high of -$42.42 million, reached on March 31, 2018.
Performance
BBIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BBIO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.6% | -904.5% | -20.7% |
| 3 y3 years | +17.9% | +29.6% | +0.3% |
| 5 y5 years | -58.3% | -27.4% | -78.7% |
BBIO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.6% | +22.6% | -819.3% | +46.1% | -61.3% | +2.5% |
| 5 y | 5-year | -58.3% | +22.6% | -819.3% | +46.1% | -78.7% | +2.5% |
| alltime | all time | -910.8% | +22.6% | -819.3% | +46.1% | -1214.6% | +2.5% |
BBIO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$127.47M(-46.1%) | -$557.68M(+25.9%) |
| Dec 2024 | -$442.90M(-22.6%) | -$236.41M(+67.4%) | -$442.90M(+24.2%) |
| Sep 2024 | - | -$141.19M(+168.4%) | -$356.55M(-4.8%) |
| Jun 2024 | - | -$52.61M(+314.6%) | -$374.54M(-18.9%) |
| Mar 2024 | - | -$12.69M(-91.5%) | -$462.04M(-19.2%) |
| Dec 2023 | -$571.96M(+41.5%) | -$150.06M(-5.7%) | -$571.96M(+5.4%) |
| Sep 2023 | - | -$159.18M(+13.6%) | -$542.48M(+7.7%) |
| Jun 2023 | - | -$140.11M(+14.3%) | -$503.67M(+45.6%) |
| Mar 2023 | - | -$122.61M(+1.7%) | -$345.84M(-14.4%) |
| Dec 2022 | -$404.21M(-25.1%) | -$120.58M(+0.2%) | -$404.21M(-3.9%) |
| Sep 2022 | - | -$120.37M(-779.3%) | -$420.78M(-6.6%) |
| Jun 2022 | - | $17.72M(-109.8%) | -$450.36M(-19.5%) |
| Mar 2022 | - | -$180.99M(+32.0%) | -$559.32M(+3.6%) |
| Dec 2021 | -$539.68M | -$137.15M(-8.5%) | -$539.68M(+2.5%) |
| Sep 2021 | - | -$149.95M(+64.4%) | -$526.59M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$91.23M(-43.5%) | -$495.88M(-6.5%) |
| Mar 2021 | - | -$161.34M(+30.1%) | -$530.11M(+13.1%) |
| Dec 2020 | -$468.83M(+67.5%) | -$124.06M(+4.0%) | -$468.83M(+10.1%) |
| Sep 2020 | - | -$119.24M(-5.0%) | -$425.88M(+16.6%) |
| Jun 2020 | - | -$125.46M(+25.4%) | -$365.19M(+17.0%) |
| Mar 2020 | - | -$100.07M(+23.4%) | -$312.13M(+11.5%) |
| Dec 2019 | -$279.82M(+67.7%) | -$81.11M(+38.5%) | -$279.82M(+13.4%) |
| Sep 2019 | - | -$58.55M(-19.1%) | -$246.77M(+7.7%) |
| Jun 2019 | - | -$72.39M(+6.8%) | -$229.14M(+19.2%) |
| Mar 2019 | - | -$67.77M(+41.0%) | -$192.25M(+15.2%) |
| Dec 2018 | -$166.90M(+280.9%) | -$48.06M(+17.4%) | -$166.90M(+40.4%) |
| Sep 2018 | - | -$40.92M(+15.3%) | -$118.84M(+52.5%) |
| Jun 2018 | - | -$35.50M(-16.3%) | -$77.92M(+83.7%) |
| Mar 2018 | - | -$42.42M | -$42.42M |
| Dec 2017 | -$43.82M | - | - |
FAQ
- What is BridgeBio Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for BridgeBio Pharma?
- What is BridgeBio Pharma annual EBIT year-on-year change?
- What is BridgeBio Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly EBIT year-on-year change?
- What is BridgeBio Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for BridgeBio Pharma?
- What is BridgeBio Pharma TTM EBIT year-on-year change?
What is BridgeBio Pharma annual earnings before interest & taxes?
The current annual EBIT of BBIO is -$442.90M
What is the all time high annual EBIT for BridgeBio Pharma?
BridgeBio Pharma all-time high annual earnings before interest & taxes is -$43.82M
What is BridgeBio Pharma annual EBIT year-on-year change?
Over the past year, BBIO annual earnings before interest & taxes has changed by +$129.06M (+22.56%)
What is BridgeBio Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of BBIO is -$127.47M
What is the all time high quarterly EBIT for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly earnings before interest & taxes is $17.72M
What is BridgeBio Pharma quarterly EBIT year-on-year change?
Over the past year, BBIO quarterly earnings before interest & taxes has changed by -$114.78M (-904.55%)
What is BridgeBio Pharma TTM earnings before interest & taxes?
The current TTM EBIT of BBIO is -$557.68M
What is the all time high TTM EBIT for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM earnings before interest & taxes is -$42.42M
What is BridgeBio Pharma TTM EBIT year-on-year change?
Over the past year, BBIO TTM earnings before interest & taxes has changed by -$95.64M (-20.70%)